Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
J Clin Microbiol ; 62(8): e0004024, 2024 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-38990041

RESUMEN

Yersinia enterocolitica (Y. enterocolitica) is the most frequent etiological agent of yersiniosis and has been responsible for several national outbreaks in Norway and elsewhere. A standardized high-resolution method, such as core genome Multilocus Sequence Typing (cgMLST), is needed for pathogen traceability at the national and international levels. In this study, we developed and implemented a cgMLST scheme for Y. enterocolitica. We designed a cgMLST scheme in SeqSphere + using high-quality genomes from different Y. enterocolitica biotype sublineages. The scheme was validated if more than 95% of targets were found across all tested Y. enterocolitica: 563 Norwegian genomes collected between 2012 and 2022 and 327 genomes from public data sets. We applied the scheme to known outbreaks to establish a threshold for identifying major complex types (CTs) based on the number of allelic differences. The final cgMLST scheme included 2,582 genes with a median of 97.9% (interquartile range 97.6%-98.8%) targets found across all tested genomes. Analysis of outbreaks identified all outbreak strains using single linkage clustering at four allelic differences. This threshold identified 311 unique CTs in Norway, of which CT18, CT12, and CT5 were identified as the most frequently associated with outbreaks. The cgMLST scheme showed a very good performance in typing Y. enterocolitica using diverse data sources and was able to identify outbreak clusters. We recommend the implementation of this scheme nationally and internationally to facilitate Y. enterocolitica surveillance and improve outbreak response in national and cross-border outbreaks.


Asunto(s)
Brotes de Enfermedades , Genoma Bacteriano , Tipificación de Secuencias Multilocus , Yersiniosis , Yersinia enterocolitica , Yersinia enterocolitica/genética , Yersinia enterocolitica/clasificación , Yersinia enterocolitica/aislamiento & purificación , Tipificación de Secuencias Multilocus/métodos , Humanos , Yersiniosis/epidemiología , Yersiniosis/microbiología , Yersiniosis/diagnóstico , Noruega/epidemiología , Genoma Bacteriano/genética , Monitoreo Epidemiológico , Epidemiología Molecular/métodos , Genotipo , Técnicas de Tipificación Bacteriana/métodos
2.
BMC Microbiol ; 24(1): 248, 2024 Jul 06.
Artículo en Inglés | MEDLINE | ID: mdl-38971718

RESUMEN

BACKGROUND: The usage of fluoroquinolones in Norwegian livestock production is very low, including in broiler production. Historically, quinolone-resistant Escherichia coli (QREC) isolated from Norwegian production animals rarely occur. However, with the introduction of a selective screening method for QREC in the Norwegian monitoring programme for antimicrobial resistance in the veterinary sector in 2014; 89.5% of broiler caecal samples and 70.7% of broiler meat samples were positive. This triggered the concern if there could be possible links between broiler and human reservoirs of QREC. We are addressing this by characterizing genomes of QREC from humans (healthy carriers and patients) and broiler isolates (meat and caecum). RESULTS: The most frequent mechanism for quinolone resistance in both broiler and human E. coli isolates were mutations in the chromosomally located gyrA and parC genes, although plasmid mediated quinolone resistance (PMQR) was also identified. There was some relatedness of the isolates within human and broiler groups, but little between these two groups. Further, some overlap was seen for isolates with the same sequence type isolated from broiler and humans, but overall, the SNP distance was high. CONCLUSION: Based on data from this study, QREC from broiler makes a limited contribution to the incidence of QREC in humans in Norway.


Asunto(s)
Antibacterianos , Pollos , Farmacorresistencia Bacteriana , Infecciones por Escherichia coli , Escherichia coli , Quinolonas , Animales , Pollos/microbiología , Escherichia coli/genética , Escherichia coli/efectos de los fármacos , Escherichia coli/aislamiento & purificación , Humanos , Noruega , Infecciones por Escherichia coli/veterinaria , Infecciones por Escherichia coli/microbiología , Farmacorresistencia Bacteriana/genética , Quinolonas/farmacología , Antibacterianos/farmacología , Genómica , Plásmidos/genética , Enfermedades de las Aves de Corral/microbiología , Pruebas de Sensibilidad Microbiana , Genoma Bacteriano/genética , Girasa de ADN/genética , Topoisomerasa de ADN IV/genética , Carne/microbiología , Mutación , Proteínas de Escherichia coli/genética , Ciego/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA